Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor
1991

Cathepsin D Levels in Ovarian Cancer

Sample size: 68 publication Evidence: moderate

Author Information

Author(s): G. Scambia, P. Benedetti, G. Ferrandina, F. Battaglia, G. Baiocchi, S. Mancuso

Primary Institution: Catholic University, Rome, Italy

Hypothesis

Does Cathepsin D concentration correlate with pathological features and hormone receptors in ovarian cancer?

Conclusion

Ovarian tumors produce higher levels of Cathepsin D compared to normal tissues, suggesting it may be a potential prognostic marker.

Supporting Evidence

  • Cath-D levels were significantly higher in malignant tumors than in normal and benign tissues.
  • In six out of seven cases, metastatic deposits had higher Cath-D concentrations than primary tumors.
  • 66% of cases had Cath-D levels above 12 pmoles mg-1 protein.

Takeaway

This study found that ovarian cancer tissues have more Cathepsin D than normal tissues, which might help doctors understand how aggressive the cancer is.

Methodology

Cathepsin D levels were measured in ovarian tissue samples using an immunoradiometric assay.

Limitations

The study did not find a correlation between Cathepsin D levels and various pathological parameters.

Participant Demographics

Patients aged 29 to 71 years, median age 53.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication